Skip to content
AP

Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corporation Q3 FY2025 earnings call

November 13, 2025 · fiscal period ended 2025-09

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2025-11-13

Management highlights

Management Statement and Operational Highlights

  • Financial Performance: Consolidated adjusted EBITDA for Q3 2025 was $9.2 million, up 35% from prior year. Adjusted earnings per share were $0.04, up $0.14 from prior year.
  • Strategic Actions: Accelerated exit from U.K. facility and small steel distribution business AUP. U.K. exit expected to improve full year adjusted EBITDA by $7 million to $8 million.
  • Segment-Specific: FCEP saw improved demand and shipments, with year-to-date revenue up 40%. Air and Liquid had record year-to-date adjusted EBITDA, driven by strong demand in nuclear, Navy, and pharmaceutical sectors, and ongoing capacity expansions.
View in transcript ↓

Segment performance

Segment Performance

  • Forged and Cast Engineered Products (FCEP): Q3 2025 net sales were $71.5 million, $6.4 million lower than Q2 2025 but $4.3 million higher than Q3 2024. Year-to-date FEP revenue increased approximately 40% to $14.4 million compared to $10.2 million last year. Segment adjusted EBITDA (excluding exit charges) was $7.1 million higher than Q2 and $0.3 million better than Q3 2024. Tariffs have impacted market dynamics, but long-term fundamentals remain strong.
  • Air and Liquid Systems: Q3 2025 revenue was 26% higher than prior year. Year-to-date revenue was nearly 7% above prior year. Segment adjusted EBITDA in Q3 was $4.4 million, up 31% from prior year. Year-to-date segment adjusted EBITDA of $12.1 million was the highest in Air and Liquid's history. Strong demand in nuclear, U.S. Navy, and pharmaceutical markets.
View in transcript ↓

Guidance

Guidance

  • Expect adjusted EBITDA to improve by $7 million to $8 million per full year post-U.K. deconsolidation, starting in early Q4 2025.
  • Air and Liquid expects continued growth in nuclear, Navy, and pharmaceutical markets due to expanding capacities and strong demand.
View in transcript ↓

Risks

Risks

  • Tariff uncertainties affecting Canadian and Mexican customers, and European imports.
  • Potential short-term supply chain fluctuations due to tariff adjustments.
View in transcript ↓

Q&A highlights

Question and Answer

Q: Discussion on U.K. closure debt and pension/asbestos liability A: Insolvency related to U.K. subsidiary, no impact on parent company. Pension and asbestos liability evaluated annually, with next evaluation in Q4.

Q: Capacity expansion and nuclear plant position A: Significant capacity expansion with new equipment from Navy funding program. Ampco is early in the nuclear plant supply chain, having supplied heat exchangers in advance of plant openings.

Q: Monetization of U.K. operations and supply from Sweden A: Proceeds from U.K. liquidation to reduce parent company's revolving credit facility debt. Sweden plant to have higher utilization, with some roll production shifted to forged rolls to meet market needs

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

November 13, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.